Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
17,261 trials
Prostate Cancer
Primary: Number of Participants With Testosterone <=0.5 Nanogram/Milliliter From Day 28 to Day 364 — 42; 41 participants
Meningitis · Meningococcemia
Primary: Geometric Mean Titers (GMTs) of Serum Bactericidal Activity for Each of the 4 Vaccine Serogroups. — 1075.2; 193.6; 83.3; 9300.5 Titer
Stomatitis · Oral Mucositis
Primary: Duration of Ulcerative Oral Mucositis — 2.3; 3.2 Days
Pleural Neoplasms
Primary: Pathological Complete Response — 3 participants
Infections, Rotavirus
Primary: Number of Subjects Reporting Grade "2" or Grade "3" Fever, Vomiting or Diarrhea — 26; 28 Participants
Glioblastoma
Primary: Adverse Events With an Incidence of Greater Than or Equal to 20% — 25; 17; 17; 15 Participants
Stroke
Primary: Percentage of Participants With Revascularization of the Occluded Target Vessel — 81.2 Percentage of Participants
Influenza
Primary: Occurrence of Solicited Adverse Events Among All Subjects — 0; 0; 10; 1 Participants
Depression
Primary: Beck Depression Inventory II (Beck, Steer & Brown, 1996) — 14.27; 16.93 Points on a scale
Diabetes Mellitus, Type 2
Primary: Insulin Secretion — 56766 pmol/l * 90 minutes
Erythropoietic Protoporphyria